Recombinant human growth hormone in the treatment of Turner syndrome
Bessie E SpiliotisDivision of Pediatric Endocrinology and Diabetes, Department of Pediatrics, University of Patras, School of Medicine, Patras, GreeceAbstract: Turner syndrome (TS) is a common chromosomal disorder in women that is associated with the absence of one of the X chromosomes. Severe short...
Saved in:
Main Author: | Bessie E Spiliotis (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2008-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Recombinant Growth hormone response in Indian girls with Turner syndrome
by: Inderpal Singh Kochar, et al.
Published: (2018) -
The role of p21/CIP1/WAF1 (p21) in the negative regulation of the growth hormone/growth hormone receptor and epidermal growth factor/epidermal growth factor receptor pathways, in growth hormone transduction defect
by: Eirini Kostopoulou, et al.
Published: (2018) -
Concomitant occurrence of Turner syndrome and growth hormone deficiency
by: Jung Yu, et al.
Published: (2016) -
Health-related quality of life of young adults with Turner syndrome following a long-term randomized controlled trial of recombinant human growth hormone
by: Van Vliet Guy, et al.
Published: (2011) -
Craniofacial morphology in Turner syndrome patients treated with growth hormone
by: Jovana Julsoki, et al.
Published: (2015)